XML 52 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
REVERSE MERGER (Schedule of Business Acquisition) (Details) - Transgenomics [Member] - USD ($)
$ in Thousands
Jun. 29, 2017
Jun. 29, 2017
Business Acquisition [Line Items]    
Legacy Transgenomic common stock $ 419 $ 6,088
Fair value of preferred stock converted to common stock 29 49
Fair value of debt converted to common stock 14,000 2,398
Fair value of debt converted to preferred stock 21,100 9,796
Fair value of existing bridge notes 35,548 1,275
Fair value of warrants 13,423 1,996
Purchase consideration $ 523 $ 21,602